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1. Introduction  
Thyroid lobectomy or hemithyroidectomy is considered an adequate treatment for several 
thyroid diseases such as large benign nodules, follicular neoplasm, and some suspected 
malignancies. Thyroid lobectomy theoretically preserves sufficient functioning native 
thyroid tissue for patients to keep euthyroid status postoperatively without the need for 
thyroid hormone replacement. Still, it is known that some patients who have undergone 
hemithyroidectomy will require thyroid hormone replacement because they have developed 
hypothyroidism, which is commonly diagnosed as a result of elevated levels of thyroid-
stimulating hormone (TSH). Currently, the incidence and risk of hypothyroidism in patients 
undergoing partial thyroidectomy remains unclear. Several studies about thyroid function 
after hemithyroidectomy for benign thyroid disease have been published. The reported 
incidence of hypothyroidism ranges from 5% to 49%, with most between 15-30%. The 
incidence rates vary widely depending on the follow-up period and on how 
hypothyroidism is defined by authors. These variations have led to our interest in defining 
uniform criteria for diagnosis and treatment of postoperative hypothyroidism, thereby 
identifying patients at the greatest risk of requiring long-term thyroid hormone 
replacement.  
Hypothyroidism after hemithyroidectomy remains an unpredictable complication. Several 
results have pointed to the degree of lymphocytic infiltration within the thyroid gland and 
the amount of thyroid remnant as possible predictors of hypothyroidism. Other reports 
about risk factors for hypothyroidism have indicated links to the preoperative TSH level, 
anti-TPO antibodies, multinodular goiter, and preoperative thyrotoxicosis. However, 
definite risk factors for development of hypothyroidism after hemithyroidectomy have yet 
to be completely characterized. 
Patients with symptomatic hypothyroidism such as weight gain, fatigue, generalized edema, 
muscle pain and lethargy warrant treatment, as do patients with mild disease and medical 
comorbidities. Of late, some authors have advocated thyroxine replacement for all patients 
undergoing hemithyroidectomy to prevent progression of multi-nodular changes in the 
contralateral lobe, but others have asserted that it should not be necessary to prescribe 
thyroxine replacement for all patients. Patients who develop chronic hypothyroidism after 
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hemithyroidectomy may require life-long thyroxine replacement, as well as routine laboratory 
tests. The side effects of long-term thyroid hormone replacement have included arrhythmias, 
osteopenia, changes of lipid metabolism, and mood changes. Early diagnosis of the subclinical 
state, followed by treatment of symptomatic hypothyroidism should be priorities.  
The risk of postoperative hypothyroidism after thyroid lobectomy is not negligible and 
should not be overlooked. Careful monitoring for patients who may develop 
hypothyroidism will improve patient care. At present, there is no universal algorithm for 
monitoring postoperative residual thyroid function in patients who have undergone 
hemithyroidectomy. In most patients, the follow-up is dependent on the discretion of the 
physician in charge based on clinical suspicion or the development of definite symptoms. 
From a practical viewpoint, only select patients at risk of developing hypothyroidism after 
partial thyroidectomy have been followed on a regular schedule.  
In this chapter, we evaluate the incidence, natural history, and risk factors for 
hypothyroidism in patients undergoing thyroid lobectomy, and we review postoperative 
thyroid hormone replacement. We also aim to clarify a uniform monitoring and follow-up 
protocol for patients after hemithyroidectomy.  
2. Hypothyroidism after hemithyroidectomy 
2.1 Definition of hypothyroidism 
Thyroid hormones are essential regulators of metabolism and transport, and thyroid 
hormone deficiencies of any cause result in hypothyroidism. Hypothyroidism may be 
primary, i.e., resulting from a defect in the thyroid gland itself, or secondary, i.e., resulting 
from a TSH deficiency related to pituitary or hypothalamic disease. Although there is no 
universally accepted definition of normal thyroid function, thyroid function assays have 
indicated that a TSH concentration of 4.5 uIU/L is the upper limit of normal (Surks et al., 
2004; Hollowell et al., 2002). 
Thyroid hormone deficiency affects nearly all organs and functions in the human body 
(Laurberg et al., 2005). The changes induced by hypothyroidism include the slowing and 
lowering of processes, which may mimic the alterations associated with aging. Symptoms 
and signs of hypothyroidism differ according to the severity and duration of the thyroid 
deficiency, the age of the patient, and the occurrence of other systemic diseases. Early 
symptoms of hypothyroidism are often nonspecific and insidious in onset and can include 
fatigue, lethargy, constipation, cold intolerance, muscle stiffness and cramping, carpal 
tunnel syndrome, decreased libido, depression, hair loss, menstrual irregularity, 
menorrhagia, and infertility. With little functional thyroid reserve, the severity of 
hypothyroidism can progress to a clinical picture of myxedema. At this stage, patients 
appear bored, depressed, and hypokinetic, with a hoarse voice, dull, expressionless faces, 
sparse hair, and a large tongue. The skin is cool to the touch, dry, and rough, with facial and 
periorbital puffiness and often generalized edema. Fluid may collect in various parts of the 
body, and pleural effusion, pericardial effusion, and ascites are common. On physical 
examination or chest X-ray, the cardiac silhouette may appear enlarged, due to chamber 
dilatation or pericardial effusion. Constipation is common, due to slowed gastrointestinal 
motility, and a dynamic ileus may cause megacolon or intestinal obstruction. A psychiatric 
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syndrome (“myxedema madness”) has been described, and neurologic findings include a 
delayed or hung-up relaxation phase of deep tendon reflexes, muscle weakness, and ataxia 
(Wartofsky et al., 2006).  
Hypothyroidism can be classified as subclinical or overt (clinical), with the latter defined as 
abnormal serum TSH and free T4 concentrations, or as the development of hypothyroidism 
symptoms. Subclinical hypothyroidism is a mild degree of biochemical abnormality, 
characterized by increased serum TSH and T4 estimates within the laboratory reference 
range (Wartofsky et al., 2006). Although the cause and clinical abnormalities observed in 
individuals with subclinical hypothyroidism do not differ from those with overt 
hypothyroidism, including high TSH and low T4 concentrations, the former is milder. Either 
form of hypothyroidism, however, is a potential consequence of hemithyroidectomy and 
has a substantial impact on postoperative patient outcomes and quality of life. 
Hypothyroidism occurring soon after thyroid surgery or radioiodine therapy may 
normalize spontaneously after some months. In these patients, partial substitution therapy 
or control for some months before therapy is appropriate. This chapter focuses only on overt 
or subclinical hypothyroidism following hemithyroidectomy. 
2.2 Incidence 
Hemithyroidectomy, defined as the complete removal of the unilateral lobe, isthmus and 
where present, the pyramidal lobe of the thyroid, is a relatively common procedure for a 
variety of thyroid pathologies. Hemithyroidectomy is commonly indicated for patients with 
large benign tumors causing compressive symptoms or cosmetic concerns, as well as for 
toxic nodules. It is also indicated for patients with follicular lesions classified as 
“indeterminate” thyroid nodules to exclude thyroid carcinoma, as long as these nodules do 
not show any clinical features of malignancy other than in fine needle aspiration cytology 
(FNAC) results. Thyroid lobectomy is performed in patients with indeterminate nodules 
because 20-30% of nodules harbor thyroid malignancy. Hemithyroidectomy and central 
compartment lymph node dissection (CCND) are also usually performed on patients in 
Korea and Japan with papillary thyroid microcarcinoma (PTMC) (Tomoda et al., 2011). The 
worldwide incidence of PTMC has increased significantly, probably due to more frequent 
use of thyroid ultrasonography (US) as an essential part of initial health examinations. 
Although total thyroidectomy is the most common standard operation for thyroid cancers, 
hemithyroidectomy rather than total thyroidectomy may be preferred for low risk patients 
with PTMC to eliminate the risks of permanent hypocalcemia and bilateral recurrent and 
superior laryngeal nerve palsy associated with total thyroidectomy. In addition, 
hemithyroidectomy theoretically leaves sufficient functioning native thyroid tissue for the 
patient to remain euthyroid without the need for thyroid hormone replacement.  
Several studies have evaluated thyroid function after hemithyroidectomy for benign thyroid 
disease. The reported incidence of hypothyroidism after hemithyroidectomy has been found 
to vary from 5.0% to 49%, with most studies reporting a range of 15-30% (Wormald et al., 
2008; Chu et al., 2011; Su et al, 2009; Spanheimer et al, 2011). This disparity in results is 
partially due to differences in their definition of hypothyroidism and to differences in length 
of follow-up. Hypothyroidism, both clinical and subclinical, is a potential consequence of 
hemithyroidectomy and has been associated with a number of adverse clinical outcomes. 
However, hypothyroidism after hemithyroidectomy is an under-reported or under-
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recognized complication, with patients most often monitored only for a short time 
postoperatively. Table 1 summarizes the incidence of hypothyroidism after 
hemithyroidectomy.  
 
Author 
(year) 
Patients (n)
Time for TSH 
measurement to 
determine 
postoperative 
hypothyroidism 
Definition of 
postoperative 
hypothyroidism 
Incidence 
(overt or subclinical) (%) 
McHenry, et al. 
(2000) 
71 
At least 5 weeks 
after operation 
Serum  
TSH>3.59μIU/L 
Total: 25/71 (35%) 
(Overt: 9/71 (12.7%) 
Subclinical: 16/71 (22.5%)) 
Miller, et al. 
(2006) 
90 
At least 8-10 weeks 
after surgery 
Serum 
TSH>6.0mIU/L 
 
Total: 24/90 (27%) 
 
Seiberling, et al. 
(2007) 
58 
At least 6 weeks 
after surgery 
Serum 
TSH>4.0μIU/ml Total: 14/58 (24.1%) 
Koh, et al. 
(2008) 
136 
1,2, & 6 months 
after surgery 
Serum 
TSH>4.0μU/ml 
Total: 58/136 (42.6%) 
(Overt: 11/136 (8.1%) 
Subclinical: 47/136 
(34.6%)) 
Wormald, et al. 
(2008) 
82 
3,6,& 12 months 
after surgery 
Serum 
TSH>4.5μIU/L 
Total: 15/82 (18.3%) 
Overt: 5/82 (6.1%) 
Subclinical: 10/82(12.2%) 
Moon, et al. 
(2008) 
101 
2 months, and 
every 2-3 months 
(more than 1 year) 
after surgery 
Serum 
TSH>4.7μIU/L Total: 37/101 (36.6%) 
De Carlucci Jr,  
et al. 
(2008) 
168 
4 to 8 weeks after 
surgery 
Serum 
TSH>5.5mU/L 
Total: 61/186 (32.8%) 
Su, et al. 
(2009) 
294 
At least 3 months 
after surgery 
Serum 
TSH>4.0mIU/L 
Total: 32/294 (10.9%) 
Stoll, et al. 
(2009) 
547 
6 to 8 weeks after 
surgery 
Serum 
TSH>4.82μIU/mL Total: 78/547 (14.3%) 
Spanheimer,  
et al. 
(2011) 
71 
6 weeks after 
surgery 
Serum 
TSH>4.20μIU/mL Total: 24/71 (33.8%) 
Tomoda, et al. 
(2011) 
233 
At least 4-6 weeks, 
and 3 months after 
surgery 
Serum 
TSH>5.0mIU/l 
Total: 57/233 (24.4%) 
Johner, et al. 
(2011) 
117 
6 weeks(or 3 
months), 6 months 
& 12 months after 
surgery 
Serum 
TSH>5.5μIU/L 
Total: 21.6% 
(Permanent: 7.8%) 
 
Chu, et al. 
(2011) 
263 
2 weeks, 3 months, 
6 months, and 
yearly after surgery 
Serum 
TSH>5.5mIU/L 
Total: 38/263 (14.4%) 
Table 1. Incidence of posthemithyroidectomy hypothyroidism 
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Recently, however, Johner et al (2011) reported that the overall incidence of early 
postoperative hypothyroidism was 21.6%, with the incidence of permanent hypothyroidism 
only 7.8%. In addition to showing that the incidence of hypothyroidism following 
hemithyroidectomy is low, this study showed that a significant proportion of individuals 
who become biochemically hypothyroid (asymptomatic) demonstrate only a transient 
elevation in their TSH levels. The low incidence of sustained hypothyroidism supports the 
adoption of a watch-and-wait approach in patients with biochemical hypothyroidism after 
hemithyroidectomy. Previously, it was common practice to prescribe suppressive doses of 
thyroxine after hemithyroidectomy, but it is now thought that  the remaining thyroid lobe 
may compensate. Since the pituitary-thyroid axis must adapt after hemithyroidectomy, 
serial TSH measurements after surgery will identify only those individuals who remain 
biochemically hypothyroid or become symptomatic and therefore require treatment with 
thyroid hormone. This will spare a significant number of patients the need for, and potential 
risks of, long-term thyroid hormone replacement therapy.  
2.3 Natural history 
TSH is important for pathologic thyroid growth, and elevated serum TSH may contribute to 
the development of recurrent nodular or diffuse thyroid enlargement. The efficacy of 
administering TSH-suppressive doses of thyroxine to prevent thyroid nodule recurrence 
after surgery has not been determined. Most studies that reported a beneficial effect of 
suppressive therapy in reducing recurrent nodular thyroid disease after thyroidectomy have 
been from areas of iodine deficiency, whereas most studies that found no benefit of 
suppressive therapy have been from iodine-sufficient areas (McHenry & Slusarczyk, 2000).  
Hypothyroidism is now one of the most common morbidities observed after 
hemithyroidectomy. Most patients will continue to have normal thyroid function after 
hemithyroidectomy, although some will have mildly elevated TSH during the perioperative 
period that may normalize without pharmacologic intervention due to compensation by the 
remaining thyroid lobe. This may be characterized by both an increase in serum TSH 
concentration and an augmented release of TSH in response to TRH signaling (Lombardi et 
al, 1983) (Campion et al., 1995), adaptive mechanisms that may persist for 12-18 months 
after surgery. Animal experiments have shown that serum TSH concentration declines 
initially, subsequently returning to normal with compensatory hypertrophy of the 
remaining thyroid lobe followed by a significant elevation in serum TSH for as long as 5 
months after surgery (Clark et al., 1976). Compensatory hypertrophy of the remaining 
thyroid lobe has been observed histologically following hemithyroidectomy (Marine et al., 
1926).  
Some patients with symptomatic hypothyroidism require treatment, as do patients with 
mild hypothyroidism and medical comorbidities. The physiological and clinical signs of 
hypothyroidism are generally completely reversed by appropriate thyroid hormone 
replacement treatment. Some physicians therefore advocate thyroxine replacement to 
prevent progression of multinodular changes in the contralateral lobe, whereas others 
prescribe thyroxine replacement for all patients after hemithyroidectomy. The possibility of 
compensatory hypertrophy of the residual lobe should be balanced by the need for close 
follow-up of patients with borderline thyroid reserves, and the potential for deterioration at 
times of physiological stress and progression of underlying thyroiditis. Routine thyroxine 
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replacement may be recommended, rather than close follow-up monitoring, for some post-
hemithyroidectomy patients with risk factors, such as elevated thyroid antibody 
concentrations or histologic evidence of autoimmune thyroiditis (Su et al., 2009). In contrast, 
other researchers have reported that elevated serum TSH concentration alone may not 
justify the initiation of thyroid hormone replacement, since nearly 70% of individuals who 
developed biochemical (asymptomatic) hypothyroidism during the early postoperative 
period after hemithyroidectomy recovered normal thyroid function without pharmacologic 
intervention (Johner et al., 2011). Therefore, determination of the true indication is important 
prior to initiating thyroid hormone replacement therapy. 
A small number of patients who develop hypothyroidism after thyroid lobectomy require 
life-long thyroid hormone replacement, as well as routine laboratory examinations and 
medical adjustments. Furthermore, chronic thyroxine therapy may be associated with 
adverse effects, including arrhythmias (atrial fibrillation) or loss of calcium from the bones 
resulting in osteopenia or osteoporosis. High serum cholesterol concentrations may result in 
cardiac sclerosis with all its complications, suggesting that hormone replacement therapy be 
delayed. Thus, an increased ability to recognize which patients are most at risk for 
developing hypothyroidism will improve patient care. Although closer monitoring or earlier 
initiation of thyroid hormone replacement therapy may be advisable for these high-risk 
patients, no specific TSH concentration alone is indicative of increased risk of permanent or 
overt hypothyroidism, suggesting that transient biochemical hypothyroidism be closely 
monitored rather than routinely treated. Accurate detection and diagnosis of sustained 
hypothyroidism after thyroid surgery is also important to avoid its associated morbidity 
and mortality (Johner et al., 2011). 
2.4 Risk factors 
Among the factors found to predict hypothyroidism after hemithyroidectomy are patient 
age, sex, preoperative TSH concentration, the presence of anti-thyroid antibodies, 
autoimmune thyroiditis in the excised lobe, and volume of remnant thyroid bed. Although 
these factors are also important in determining treatment plans for patients with thyroid 
disease, the correlation between risk factors and onset of hypothyroidism remains unclear. 
Table 2 shows a summary of risk factors that predict hypothyroidism after 
hemithyroidectomy. 
 
Author 
(year) 
Incidence of 
posthemithyroidectomy 
hypothyroidism 
Risk factors 
(Postoperative hypothyroidism vs. Euthyroid state) 
McHenry, et al. 
(2000) 
35% 
Higher preoperative serum TSH level (μIU/L) 
(1.94±1.00 vs. 1.10±0.74) 
Miller, et al. 
(2006) 
27% 
Hashimoto’s thyroiditis, 
multinodular goiter, higher preoperative serum 
TSH level (mIU/L) 
(3.15±1.14 vs. 1.95±0.92) 
Seiberling, et al. 
(2007) 
24.1% 
Higher preoperative serum TSH level (μIU/ml) 
(2.39 vs. 1.07), chronic inflammation (lymphocytic 
thyroiditis or Hashimoto’s thyroiditis) 
(50.0% vs. 6.8%)
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Author 
(year) 
Incidence of 
posthemithyroidectomy 
hypothyroidism 
Risk factors 
(Postoperative hypothyroidism vs. Euthyroid state) 
Koh, et al. 
(2008) 
42.6% 
Higher preoperative serum TSH level (μU/ml) 
(2.15±1.30 vs. 1.29±0.9), 
preoperative microsomal Ab, thyroglobulin Ab, 
higher grade of lymphocytic infiltration of resected 
thyroid gland 
Wormald, et al. 
(2008) 
18.3% 
Higher preoperative serum TSH level (μIU/L) 
(>1.6 vs. <1.6), 
higher grade of lymphocytic infiltration of resected 
thyroid gland 
Moon, et al. 
(2008) 
36.6% 
Higher preoperative serum TSH level (μIU/L) 
(2.46±1.16 vs. 1.22±0.89), 
BSA-adjusted remnant thyroid volume 
(2.73±1.34 vs. 3.48±1.50) 
De Carlucci Jr,  
et al. 
(2008) 
32.8% 
Higher preoperative serum TSH level (mU/L) 
(2.1 vs. 1.2), 
smaller remnant thyroid volume (mL) 
(3.9 vs. 6.0), 
right vs. left lobectomy, 
higher thyroperoxidase antibody serum levels 
Su, et al. 
(2009) 
10.9% 
High-normal preoperaitve serum TSH level; TSH 
2.5-4.0mIU/L (%) 
(18.8 vs. 3.8), 
thyroiditis in histology (%) 
(46.8 vs. 11.8), 
elevated thyroid antibodies levels (%) 
(47.8 vs. 11.5) 
Stoll, et al. 
(2009) 
14.3% 
Higher preoperative serum TSH level (μIU/mL) 
(2.12 vs. 1.35), 
lower mean free T4 (ng/dL) 
(1.03 vs. 1.34), 
Hashimoto’s thyroiditis 
Spanheimer, et al. 
(2011) 
33.8% Thyroiditis on surgical pathology 
Tomoda, et al. 
(2011) 
24.4% 
Higher preoperative serum TSH level (mIU/l) 
(2.73±1.36 vs. 1.24±0.82), 
older age (years) 
(56.2±13 vs. 48.97±15) 
Johner, et al. 
(2011) 
21.6% 
Higher preoperative serum TSH level, 
high degree of lymphocytic infiltraiton, 
high degree of germinal center formation 
Chu, et al. 
(2011) 
14.4% 
Older age, higher preoperative serum TSH level, 
longer follow-up period, more frequent thyroiditis 
on histology, lighter resected tissue weight, 
positive antimicrosomal antibodies. 
* By multivariate analysis, only resected tissue 
weight, and concomitant thyroiditis on histology 
turned out to be independent predicting factors. 
Table 2. Risk factors for predicting posthemithyroidectomy hypothyroidism 
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Some known risk factors can be determined only after surgery, such as lymphocytic 
infiltration, associated thyroiditis, and the weight of the resected gland, whereas others, such 
as preoperative TSH concentration, age, and presence of thyroid autoantibody, are known 
preoperatively. In addition, the remnant thyroid volume may be easily measured from 
preoperative US. Because most patients scheduled for hemithyroidectomy due to thyroid 
nodules are evaluated by thyroid US, the remnant thyroid volume could be easily determined, 
allowing the surgeon to decide whether to perform a diagnostic hemithyroidectomy.  
2.4.1 Elevated preoperative TSH concentration 
Preoperative TSH concentration is significantly associated with postoperative 
hypothyroidism. In addition, studies using a TSH cutoff value, such as >1.6 or >2.0 uIU/mL, 
have found that patients with elevated TSH are 7-10 times more likely to develop 
hypothyroidism after surgery. Thus, “normally elevated” preoperative TSH >1.5 uIU/mL, 
especially when combined with lower preoperative T4 concentrations or specific antibodies, 
may indicate a potentially increased risk of hypothyroidism after hemithyroidectomy, 
allowing appropriate preoperative counseling of patients (Table 2). 
2.4.2 Degree of chronic inflammation and autoimmune disease 
2.4.2.1 Hashimoto’s thyroiditis and presence of autoantibodies 
Thyroiditis is also associated with postoperative hypothyroidism. Hashimoto’s thyroiditis is 
an inflammatory disease that is the most common cause of hypothyroidism. Moreover, 
Hashimoto’s thyroiditis has been found to significantly increase the need for thyroid hormone 
supplementation following hemithyroidectomy. Patients diagnosed with Hashimoto’s 
thyroiditis were found to be almost four times more likely to develop hypothyroidism after 
hemithyroidectomy (Stoll et al., 2009). Hashimoto’s thyroiditis is also characterized by intense 
lymphocytic infiltration of the thyroid and the presence of thyroid autoantibodies. Moreover, 
several types of autoimmune thyroiditis are closely associated with circulating thyroid 
autoantibodies such as microsomal Ab and thyroglobulin Ab (Seiberling et al, 2007). The 
presence of thyroid autoantibodies was found to strongly correlate with post-
hemithyroidectomy hypothyroidism. Similar relationships have been observed among 
Hashimoto’s thyroiditis, autoimmune thyroiditis, the degree of lymphocytic infiltration, the 
presence of chronic inflammation, or detectable thyroid autoantibodies and the occurrence of 
hypothyroidism after hemithyroidectomy. The association among Hashimoto’s thyroiditis, a 
“normal elevated” TSH concentration, a low free T4 concentration, and thyroid autoantibodies 
is likely due to the underlying pathologic disease process. In addition, preoperatively 
measured thyroid autoantibodies may predict postoperative hypothyroidism. 
2.4.2.2 Degree of lymphocytic infiltration  
Lymphocytic infiltrate into the thyroid gland has been found to decrease thyroid function, 
and a semiquantitative analysis of this infiltrate usually reflects the risk of hypothyroidism. 
The degree of lymphocytic infiltration, graded on a scale of 0-IV, into the resected thyroid 
lobe may aid in predicting the development of hypothyroidism in post-hemithyroidectomy 
patients (Koh et al, 2008). An extensive review of histopathologic data, which assessed 
whether the degree of lymphocytic infiltration and germinal center formation within the 
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thyroid lobe could accurately predict the development of postoperative hypothyroidism, 
found that when inflammation was graded based on the extent of lymphocytic infiltration 
(graded 0-3) and the frequency of germinal centers was qualitatively assessed as a histologic 
measure of immunologic activation (graded 0-3), most patients with lymphocytic infiltration 
or germinal center formation in the resected thyroid lobe are at increased risk for post-
hemithyroidectomy hypothyroidism (Johner et al, 2011). Other studies have assessed the 
relationship between postoperative pathologic findings and risk of developing 
hypothyroidism, but, since these findings were detected after surgery, they could not be 
used to determine the need for postoperative thyroidectomy.  
Taken together, these findings indicate that Hashimoto’s thyroiditis and other risk factors, 
such as lymphocytic infiltration and the presence of autoantibodies, significantly increase 
the risks for developing postoperative hypothyroidism after thyroid lobectomy. 
Preoperative evaluation is therefore important in counseling patients about a possible future 
need for thyroid hormone replacement therapy.   
2.4.3 Amount of remnant thyroid gland 
One of the major risk factors for hypothyroidism after hemithyroidectomy is the amount of 
remnant thyroid gland. Small remnant thyroid volume has been recognized as a risk factor 
for hypothyroidism (De Carlucci Jr et al., 2008). Remnant thyroid volumes can be measured 
on preoperative US images and can be calculated using the equation (Miccoli et al., 2006):  
Volume = length X width X depth X π/6.  
Patients who developed post-hemithyroidectomy hypothyroidism were found to have a 
significant smaller body surface area (BSA)-adjusted remnant thyroid volume than patients 
who remained euthyroid (Moon et al, 2008). Another predictive factor may be BSA-adjusted 
remnant thyroid volume, determined by calculating remnant thyroid volume/BSA ratio. 
BSA can be calculated using the Mosteller formula:  
BSA= √(height X weight/3600). 
2.4.4 Risk scoring systems 
Risk-scoring systems that can predict hypothyroidism after hemithyroidectomy are 
summarized in Table 3. 
Having a valid model predictive of postoperative hypothyroidism is also useful when 
making follow-up plans for patients undergoing hemithyroidectomy. Most surgeons 
recommend regular postoperative visits to the clinic, although some counsel their patients to 
visit only when surgery-related symptoms develop.  
A unique risk-scoring system that can predict hypothyroidism after hemithyroidectomy was 
recently described (Tomoda et al, 2011). In this system, risk scores are calculated as the sum 
of a patient’s age and preoperative TSH concentration. The rates of hypothyroidism in 
patients with risk scores of 0, 1, 2, and 3 were found to be 3%, 20%, 39%, and 70%, 
respectively, suggesting that the potential risk of postoperative hypothyroidism should be 
discussed with patients before surgery based on this scoring system.  
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Author 
(year) 
Number 
of patients 
Risk scoring system 
Moon, et al. 
(2008) 
101 
Risk scoring system using two independent risk 
predictors (TSH level and BSA-adjusted remnant 
thyroid volume) was created based on the results of 
logistic regression analyses. 
The incidences of hypothyroidism were 5.3%, 12.1%, 
51.7%, and 85.0% according to the risk scores of 0,1,2, 
and 3, respectively. 
Stoll, et al. 
(2009) 
547 
When stratified into 3 groups based on their 
preoperative TSH measurement (˺1.5, 1.51-2.5, and 
˻2.51μIU/mL), the rate of hypothyroidism increased 
significantly at each level (13.5%, 20.5%, and 41. 3%, 
respectively) 
Tomoda, et al. 
(2011) 
233 
A risk-scoring system was calculated by summing the 
score of risk factors such as preoperative TSH level (<1, 
1-2.49, and ˻2.5μIU/ml) and patient’s age (<55, and 
˻55 year). The incidences of hypothyroidism were 3, 
20, 39, and 70% according to the risk scores of 0, 1, 2 
and 3, respectively. 
Johner, et al. 
(2011) 
117 
Assessment of the histologic scoring criteria for thyroid 
lymphocytic infiltration (score 0-3), and germinal 
centers (score 0-3) as well as classification of TSH levels 
(<5.5, 5.5-6.9, 7-14.9, and˻15μIU/L) can predict 
potential risks associated with long –term thyroid 
hormone replacement therapy. 
Table 3. Risk scoring system in posthemithyroidectomy hypothyroidism 
An alternative risk-scoring system using two factors, TSH concentration and remnant 
thyroid volume, was based on the results of logistic regression analyses (Moon et al, 2008). 
This score system was developed using independently predictive factors, with the highest 
score of each variable determined by its β regression coefficient. Logistic regression 
analysis was used to derive an equation that calculates the probability (P) of developing 
hypothyroidism after hemithyroidectomy:   
P = 1/ (1 + e- (-1.325+1.191*preoperative TSH-0.435*remnant thyroid volume). 
The incidences of hypothyroidism in patients with risk scores of 0, 1, 2, and 3 were found to 
be 5.3%, 12.1%, 51.7%, and 85.0%, respectively, with the model having an overall accuracy in 
predicting post-hemithyroidectomy hypothyroidism of about 77. 2%.  
In summary, elevated preoperative TSH concentration, Hashimoto’s thyroiditis, small 
remnant thyroid volume, and/or advanced age are associated with increased risk of 
developing hypothyroidism and a greater likelihood of requiring thyroid hormone 
supplementation after hemithyroidectomy. Patient counseling on the need for hormone 
replacement should therefore be based on these factors.  
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2.5 Postoperative thyroid hormone replacement after hemithyroidectomy 
Hypothyroidism is an underappreciated sequel of hemithyroidectomy. It is most often 
mild and subclinical, requiring low doses of thyroid hormone to normalize serum TSH 
concentrations. Hypothyroidism has been reported in up to one third of euthyroid 
patients who undergo hemithyroidectomy. Formerly, it was common practice to routinely 
start patients with nodular thyroid disease on “prophylactic” TSH-suppressive doses of 
thyroid hormone (L-thyroxine) following hemithyroidectomy to prevent recurrence 
(Gharib & Mazzaferri, 1998), based on the hypothesis that suppression of the 
hypothalamic-pituitary axis would reduce the risk of abnormalities developing in the 
contralateral thyroid remnant. Thus, routine administration of L-thyroxine to 
hemithyroidectomy patients could be expected to decrease the incidence of 
hypothyroidism. More recently, however, L-thyroxine (TSH-suppression therapy) has not 
been not routinely prescribed for all patients after hemithyroidectomy, largely due to its 
questionable efficacy in thyroid suppression and prevention of the development of 
nodules in the remaining contralateral thyroid lobe. In addition, thyroxine administration 
may cause subclinical hyperthyroidism, which has been associated with possible side 
effects including decreased bone mineral density, particularly in postmenopausal women, 
a three-fold increase in the incidence of atrial fibrillation, and aggravation of ischemic 
heart disease (Mchenry & Slusarczyk, 2000). Therefore, early detection of postoperative 
hypothyroidism and treatment with L-thyroxine may inhibit the development of overt 
hypothyroidism and its potential complications. Although administration of thyroid 
hormone to suppress serum TSH levels in euthyroid patients may not be of value, 
treatment of patients with elevated TSH is important for relieving the symptoms of 
hypothyroidism and may be important in reducing recurrent thyroid disease. 
Administration of thyroxine after hemithyroidectomy may also require long-term 
monitoring of thyroid function and it has not been determined how long these patients 
should continue on thyroxine. These problems encouraged us to investigate the frequency 
of hypothyroidism following hemithyroidectomy, as well as its potential risk factors and 
management.  
The unfavorable side effects of TSH-suppressive doses of thyroid hormone are known, 
whereas replacement doses of thyroxine have not been associated with the adverse sequelae 
observed with TSH-suppressive doses of thyroxine. Patients with postoperatively elevated 
TSH concentrations may represent a subgroup at high risk for the development of recurrent 
nodular or diffuse thyroid enlargement. Normalization of serum TSH concentrations may 
help minimize the potential negative effects of elevated serum TSH concentrations without 
subjecting patients to the adverse sequelae associated with TSH-suppressive doses of L-
thyroxine. Therefore, the selective use of L-thyroxine therapy for patients with elevated TSH 
after hemithyroidectomy may help prevent recurrent nodular or diffuse thyroid 
enlargement without the unnecessary administration of L-thyroxine to patients with a 
normal serum TSH level and exposing them to its harmful effects (McHenry and Slusarczyk, 
2000).  
In summary, hypothyroidism after hemithyroidectomy is usually mild and asymptomatic, 
and can be treated with lower than normal replacement doses of L-thyroxine to maintain 
serum TSH concentrations within their normal range.  
www.intechopen.com
 
Hypothyroidism – Influences and Treatments 
 
46
2.6 Post-hemithyroidectomy follow-up guidelines 
Theoretically, a single thyroid lobe should possess enough functioning thyrocytes for a 
patient to remain euthyroid. In fact, many surgeons and patients choose hemithyroidectomy 
owing to the belief that postoperative thyroid hormone therapy will not be required. 
However, patients with risk factors for hypothyroidism, such as severe preoperative 
thyroiditis, may not have sufficient thyroid tissue remaining after thyroid lobectomy. Thus, 
all patients who undergo hemithyroidectomy should be counseled regarding the potential 
need for lifelong thyroid hormone therapy.  
There is no widely accepted guideline or algorithm for the monitoring of thyroid function 
after hemithyroidectomy, leaving hypothyroidism as the most common resulting 
complication. Follow-up guidelines vary widely and generally consist of a single 
postoperative measurement of TSH. Some patients may not be examined at all until the 
development of overt hypothyroidism. If thyroid dysfunction is detected, the decision to 
start thyroid hormone replacement therapy is usually based on the preference of the treating 
physician, patient symptoms, and the degree and duration of TSH elevation, rather than on 
evidence obtained from clinical trials. Therefore, it is important to identify those patients 
who are at risk of developing hypothyroidism soon after surgery so that they can be more 
attentively monitored using thyroid function tests. Additionally, it would be of benefit to 
identify risk factors predictive of the development of early hypothyroidism.  
One of the difficulties in monitoring thyroid function other than thyroid hormone 
concentrations after hemithyroidectomy is that many symptoms of subclinical 
hypothyroidism are nonspecific. Although most physicians recommend regular 
postoperative visits, some recommend visits only when patients develop surgery-related 
symptoms. Although routine and continuous long-term monitoring of thyroid hormone 
concentrations after hemithyroidectomy is a possible solution, it is often ineffective and not 
cost effective due to unnecessary hospital visits. In contrast, unrecognized hypothyroidism 
after hemithyroidectomy may have an unfavorable effect on a patient’s general health. This 
may inevitably result in overt hypothyroidism in some patients, increasing the risks of 
developing cardiovascular and/or neuropsychiatric diseases. To overcome this dilemma, 
preoperative risk factors for hypothyroidism after hemithyroidectomy have been 
formulated to identify high-risk patients. Table 4 summarizes several follow-up protocols 
followed after hemithyroidectomy.  
In most patients, hypothyroidism after hemithyroidectomy manifests as an increased serum 
TSH concentration within 3-12 months after surgery. Moreover, hypothyroidism in most of 
these patients is rarely severe or progressive. Therefore, patients who are postoperatively 
euthyroid rarely go on to develop hypothyroidism, making yearly evaluations by measuring 
serum TSH concentrations sufficient. Thus, most thyroid function should be monitored once 
yearly for life (McHenry & Sulsarczyk, 2000; Miller et al., 2006). 
The pituitary-thyroid axis undergoes adaptation following partial thyroidectomy, with most 
patients showing an increase in serum TSH at 1 month (Tomoda et al, 2011). Since most 
patients who will develop subclinical hypothyroidism will not do so within the first 3 
months after surgery, it may be advisable to measure TSH concentration 4 weeks and 3 
months after surgery. At 3 months, patients with subclinical hypothyroidism (>10 uIU/ml) 
may be prescribed L-thyroxine. TSH concentrations should again be measured at 6 and 12 
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months, and every 6 or 12 months thereafter, unless patients manifest overt symptoms of 
hypothyroidism. 
 
Author 
(year) 
Recommended follow-up protocol 
McHenry, et al. 
(2000) 
All symptomatic patients should be treated with L-T4 replacement. 
If it is elected not to treat asymptomatic patients, they should have a 
baseline serum fT4 and total T3 level measured and a yearly 
evaluation including measurement of serum fT4, T3, TSH levels to 
assess for progression to overt hypothyroidism. 
Miller, et al. 
(2006) 
Recommendation is to obtain a postoperative TSH measurement 8 to 
12 weeks after surgery, followed by the measurement of TSH levels 
at 6 months and 12 months after surgery. 
If the TSH level is normal at 12 months, biannual to annual 
determination of TSH levels was encouraged unless symptoms of 
hypothyroidism manifest. 
Koh, et al. 
(2008) 
If preoperative risk factors (presence of microsomal Ab and 
thyroglobulin Ab, or higher degree of lymphocytic infiltration of 
resected thyroid gland) were present, these patients were to be 
follow up at least for 12 months with explanation of possibility of 
developing postsurgical hypothyroidism. 
Wormald, et al. 
(2008) 
Patients with risk factors (raised TSH level or lymphocytic 
infiltration) should undergo thyroid function tests at 3,6,12 months 
and annually thereafter postoperatively. In all other patients, testing 
of thyroid function once at 1-year is sufficient. 
Moon, et al. 
(2008) 
Frequent follow-up and thyroid function monitoring can be tailored 
to high-risk patients if a valid prediction model can be established in 
prospective studies. 
Su, et al. 
(2009) 
TSH monitoring at 6 months, 12 months, and then yearly for 2 years 
was recommended for asymptomatic patients. High-risk patients 
should have serial TSH for the first year, then yearly thereafter. 
Tomoda, et al. 
(2011) 
Postoperative TSH level should be checked 4 weeks after surgery 
and again 3 months. At 3 months after operation, the decision 
regarding prescription of levothyroxine to patients with subclinical 
hypothyroidism (more than 10μIU/ml). After 3 months after 
operation, the measurement of TSH levels was recommended at 6 
and 12 months after surgery. If the TSH level is normal at 12 months, 
biannual to annual determination of TSH levels could be checked 
unless symptoms of hypothyroidism manifest. 
Johner, et al. 
(2011) 
To obtain a postoperative TSH measurement for all patients at 6 
weeks after surgery, followed by the measurement of TSH levels at 6 
and 12 months after surgery was advised. TSH level at 3 months was 
no longer recommended because most patients displayed marked 
increase in their TSH level immediately after surgery, that 
subsequently normalized over time. 
Table 4. Recommendation protocol for follow-up after hemithyroidectomy 
Another follow-up protocol recommends that all symptomatic or asymptomatic patients 
with hypothyroidism be treated with L-thyroxine (McHenry & Slusarczyk, 2000). If 
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treatment of asymptomatic patients is not preferred, serum free T4 and total 
triiodothyronine (T3) concentrations should be measured at baseline, followed by yearly 
evaluations including measurements of serum free T4, T3, and TSH to assess the 
progression to overt hypothyroidism.  
Another recommendation is to measure TSH 8 to 12 weeks after surgery, as well as at 6 and 
12 months. If TSH concentration is normal at 12 months, it should be measured every 6 to 12 
months thereafter, unless patients develop symptoms of hypothyroidism (Miller et al., 
2006).  
A recent modification of an earlier algorithm (Johner et al, 2011) recommended that TSH be 
measured 6 and 12 months after hemithyroidectomy, indicating that the measurement of 
TSH at 3 months was no longer required because most study participants displayed marked 
increases in serum TSH concentration immediately after surgery, which subsequently 
normalized over time. This new algorithm recommended that serum TSH be measured 
biannually in asymptomatic patients with mild biochemical hypothyroidism (TSH 5.6-6.9 
uIU/L). This follow-up schedule allows for the timely detection of biochemical 
hypothyroidism and appropriate surveillance for individuals managed conservatively, with 
an expectation of eventual return to normal thyroid function.  
Although it has been suggested that all hemithyroidectomy patients be monitored for as 
long as possible, it may be more practical to use a selective monitoring strategy in which 
monitoring is dependent on the presence of risk factors.  
3. Conclusion 
The incidence of hypothyroidism after hemithyroidectomy is not negligible and should not 
be overlooked. Approximately 15-30% of patients who undergo hemithyroidectomy may 
have this complication, and some may need thyroid hormone replacement therapy. Risk 
factors such as elevated preoperative TSH levels, elevated concentrations of thyroid 
autoimmune antibodies, degree of thyroiditis, age, and residual thyroid volume are 
associated with an increased risk of hypothyroidism after hemithyroidectomy. Patients at 
increased risk for postoperative hypothyroidism should be made aware of their risk factors 
and undergo more intensive follow-up. 
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